But the results add to evidence from animal studies and reports that people are finding drugs like Ozempic and Wegovy helpful ...

President Donald Trump and HHS Secretary Robert F. Kennedy Jr. said they will be studying the "threat" to children posed by ...

How can we best treat infectious diseases in people with obesity? Hospital pharmacist and Ph.D. researcher Koen van Rhee ...

One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs ...

In ongoing trials of Eli Lilly’s (LLY) next-generation obesity drug, several trial participants are losing too much weight, STAT’s Elaine Chen ...

Allowing such medications as options could lead to significant savings from improved health, writes Kelley Koch.

The Trump administration has promised that addressing childhood obesity will be a key part of its “Make America Healthy Again ...

Check out the Quiver Quantitative site for updates on what's going on behind the scenes in DC. Follow Quiver️ • TikTok - • ...

Lilly's retatrutide shows remarkable weight loss in trials but raises concerns with side effects possibly linked to the drug like nausea and kidney stones. Read more here.

Muscle loss is a big concern for people on anti-obesity medications such as semaglutide. These ‘GLP-1 agonists’ mimic a natural gut hormone — glucagon-like peptide 1 — to suppress appetite ...

With physicians' and patients' awareness expected to increase, sales of obesity medications are estimated to reach $173.5 billion in the seven major markets (7MM - US, France, Germany, Italy ...